Dermato-Oncology: Early Detection & Targeted Therapies

Dermato-oncology continues to advance through improvements in molecular diagnostics, imaging technologies, and personalized therapeutics for skin cancers. Early detection strategies utilize high-resolution dermoscopy, AI-powered lesion analysis, and genetic biomarker profiling to identify malignancies at the earliest stages. Targeted therapies including BRAF inhibitors, immunotherapies, checkpoint blockers, and photodynamic techniques offer effective, tissue-sparing solutions with improved survival outcomes. Integration of genomic insights enhances precision in selecting therapies for melanoma, basal cell carcinoma, and squamous cell carcinoma. Advances in minimally invasive procedures and regenerative reconstruction further support functional and aesthetic recovery following cancer treatment.

    Related Conference of Dermato-Oncology: Early Detection & Targeted Therapies

    June 22-23, 2026

    28th World Dermatology and Aesthetic Congress

    London, UK
    June 25-26, 2026

    27th World Dermatology Congress

    Paris, France
    August 25-26, 2026

    26th European Dermatology Congress

    Paris, France
    September 23-24, 2026

    9th International Dermatology Conference: Skin and Body

    Barcelona, Spain
    December 03-04, 2026

    9th World Cosmetic and Dermatology Congress

    Madrid, Spain